We have shown that LigF has a multitude of breast cancer preventive potential (Fig. 9), resembling aromatase and CDK inhibitor drugs in women’s breast tissue with no uterotrophic effects in animal models. The gene discussed is CYP19A1; the disease is breast carcinoma.